These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8998673)

  • 1. [Aquaretic agents].
    Bosch-Marcé M; Clària J; Jiménez W
    Gastroenterol Hepatol; 1996 Nov; 19(9):472-7. PubMed ID: 8998673
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aquaretic agents].
    Jiménez W
    Nefrologia; 2002; 22 Suppl 5():52-5. PubMed ID: 12107918
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention.
    Bosch-Marcé M; Poo JL; Jiménez W; Bordas N; Leivas A; Morales-Ruiz M; Muñoz RM; Pérez M; Arroyo V; Rivera F; Rodés J
    J Pharmacol Exp Ther; 1999 Apr; 289(1):194-201. PubMed ID: 10087004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
    Ferguson JW; Therapondos G; Newby DE; Hayes PC
    Clin Sci (Lond); 2003 Jul; 105(1):1-8. PubMed ID: 12639215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vasopressin in impaired water excretion in conscious rats with experimental cirrhosis.
    Linas SL; Anderson RJ; Guggenheim SJ; Robertson GL; Berl T
    Kidney Int; 1981 Aug; 20(2):173-80. PubMed ID: 7289402
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disorders of body water regulation and the therapy--vasopressin antagonists].
    Ishikawa S; Saito T
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1654-9. PubMed ID: 9410978
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasopressin and disorders of water balance: the physiology and pathophysiology of vasopressin.
    Ball SG
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):417-31. PubMed ID: 17761027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular bases for water/salt retention in experimental liver cirrhosis: aquaporins and renal sodium transporters].
    Fernández-Llama P
    Nefrologia; 2002; 22 Suppl 5():29-33. PubMed ID: 12107914
    [No Abstract]   [Full Text] [Related]  

  • 9. Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention.
    Bosch-Marcé M; Jiménez W; Angeli P; Leivas A; Clària J; Graziotto A; Arroyo V; Rivera F; Rodés J
    Gastroenterology; 1995 Jul; 109(1):217-23. PubMed ID: 7797019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term aquaretic efficacy of a selective nonpeptide V(2)-vasopressin receptor antagonist, SR121463, in cirrhotic rats.
    Jiménez W; Gal CS; Ros J; Cano C; Cejudo P; Morales-Ruiz M; Arroyo V; Pascal M; Rivera F; Maffrand JP; Rodés J
    J Pharmacol Exp Ther; 2000 Oct; 295(1):83-90. PubMed ID: 10991964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyponatremia in cirrhosis: from pathogenesis to treatment.
    Ginés P; Berl T; Bernardi M; Bichet DG; Hamon G; Jiménez W; Liard JF; Martin PY; Schrier RW
    Hepatology; 1998 Sep; 28(3):851-64. PubMed ID: 9731583
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis.
    Inoue T; Ohnishi A; Matsuo A; Kawai B; Kunihiro N; Tada Y; Koizumi F; Chau T; Okada K; Yamamura Y; Tanaka T
    Clin Pharmacol Ther; 1998 May; 63(5):561-70. PubMed ID: 9630829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogs.
    Brooks DP; Valente M; Petrone G; Depalma PD; Sbacchi M; Clarke GD
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1176-83. PubMed ID: 9067301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of vasopressin receptor antagonist OPC-31260 on experimental brain oedema induced by global cerebral ischaemia.
    Molnár AH; Varga C; Berkó A; Rojik I; Párducz A; László F; László FA
    Acta Neurochir (Wien); 2008 Mar; 150(3):265-71. PubMed ID: 18288441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kidney tubular transport disorders. Nephrogenic diabetes insipidus].
    Ishikawa S
    Nihon Rinsho; 1989 Jul; 47(7):1641-5. PubMed ID: 2530373
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and in vivo testing of a potential aquaretic agent.
    Kunick C; Link A; Hropot M
    Pharmazie; 1996 Aug; 51(8):601-2. PubMed ID: 8794472
    [No Abstract]   [Full Text] [Related]  

  • 17. Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis.
    Gadano A; Moreau R; Pessione F; Trombino C; Giuily N; Sinnassamy P; Valla D; Lebrec D
    J Hepatol; 2000 Jan; 32(1):38-42. PubMed ID: 10673065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antidiuretic hormone: not just a question of water].
    Fiaccadori E
    G Ital Nefrol; 2011; 28(5):468. PubMed ID: 22028255
    [No Abstract]   [Full Text] [Related]  

  • 19. [Water metabolism and its disturbances].
    Shoji M; Yasujima M
    Rinsho Byori; 1999 Dec; 47(12):1121-7. PubMed ID: 10639821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites.
    Arroyo V; Clària J; Saló J; Jiménez W
    Semin Liver Dis; 1994 Feb; 14(1):44-58. PubMed ID: 8016662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.